Abstract
Certain physiological changes caused by aerobic exercise can alter the pharmacokinetics of some drugs. A systematic review of the pharmacokinetic changes that can affect drugs as a result of aerobic exercise is provided. Eleven commonly used drugs are reviewed for their potential interaction with exercising patients. Serum concentrations of two β-blocking agents, atenolol and propranolol, and one antibiotic, doxycycline, have shown to increase as a result of exercise. No pharmacokinetic changes have been found in exercising patients taking Carvedilol or verapamil. Patients who exercise after taking digoxin experience a decreased digoxin serum concentration with an increased skeletal muscle concentration. The clearance of theophylline has been shown to decrease resulting in an increase in plasma half-life during exercise. The risk of hypoglycaemia may increase when patients with diabetes mellitus inject insulin into a muscle just prior to exercising that muscle. Increasing physical activity in patients taking warfarin has been shown to decrease the international normalised ratio. Much is still unknown regarding the interactions that exist between exercise and drug therapy. More studies need to be completed in this area before definite conclusions are made and clinical relevance can be established. Clinicians should be aware that the potential for such interactions exists, especially for drugs with a narrow therapeutic range and in patients who participate in extreme sporting activities.
Similar content being viewed by others
References
Bauer LA. Individualization of drug therapy: clinical pharmacokinetics and pharmacodynamics. In: Dipiro JT, Talbert RL, Yee GC, et al., editors. Pharmacotherapy, a pathophysiologic approach. Stamford: Appleton & Lange, 1997: 29–48
Ciccone CD. Basic pharmacokinetics and potential effect of physical therapy interventions on pharmacokinetics variables. Phys Ther 1995; 75: 343–51
Khazaeinia T, Ramsey AA. The effects of exercise on the pharmacokinetics of drugs. J Pharm Pharm Sci 2000; 3(3): 292–302
Reents S. Sport and exercise pharmacology. Champaign (IL): Human Kinetics, 2000: 13–46
The top 200 prescriptions for 2001 by number of US prescriptions dispensed [online]. Available from URL: http://www.rxlist.com [Accessed 2003 Jul 17]
McArdle WD, Katch FI, Katch VL. Exercise physiology. 3rd ed. Philadelphia (PA): Lea & Febiger, 1991: 17
Anderson KL. The cardiovascular system in exercise. In: Falls HB, editor. Exercise physiology. New York: Academic Press, 1968
American College of Sports Medicine. ACSM’s Guidelines for exercise testing and prescription. 6th ed. Baltimore (MD): Williams & Wilkins, 2000
DiPiro JT, Spruill WJ, Blouin RA, Pruemer JM. Concepts in clinical pharmacokinetics. 3rd ed. Bethesda (MD): American Society of Health Systems Pharmacists, 2002
Brouns F, Saris WHM, Rehrer NJ. Abdominal complaints and gastrointestinal function during long-lasting exercise. Int J Sports Med 1987; 8: 175–89
Cordain L, Latin RW, Behnke JJ. The effects of an anaerobic running program on bowel transit time. J Sports Med Phys Fitness 1986; 26(1): 101–4
Fernqvist E, Linde B, Ostman J, et al. Effect of physical exercise on insulin absorption in insulin-dependent diabetics comparison between human and porcine insulin. Clin Physiol 1986; 6: 489–98
Koivisto VA, Felig P. Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med 1978; 298: 79–83
Klemsdal TO, Gjesdal K, Bredesen JE. Heating and cooling of nitroglycerin patch application area modify the plasma level of nitroglycerin. Eur J Clin Pharmacol 1992; 43: 625–8
Klingman AM. A biological brief on percutaneous absorption. Drug Dev Ind Pharm 1983; 9: 521–60
van Baak MA. Influence of exercise on the pharmacokinetics of drugs. Clin Pharmacokinet 1990; 19(1): 32–43
Costill DL. Sweating: its composition and effects on body fluids. Ann N Y Acad Sci 1977; 301: 160–74
Schlaeffer F, Engelberg I, Kaplanski J, et al. Effect of exercise and environmental heat on theophylline kinetics. Respiration 1984; 45: 438–42
Swartz KD, Sidell FR. Effects of heat and exercise on the elimination of praldoxime in man. Clin Pharmacol Ther 1973; 14: 83–9
Theilade P, Hansen JM, Skovsted L, et al. Effect of exercise on thyroid parameters and metabolic clearance rate of antipyrine in man. Acta Endocrinol (Copenh) 1979; 92: 271–6
Henery JA, Iliopoulou A, Kaye CM, et al. Changes in plasma concentrations of acebutolol, propranolol, and indomethocin during physical exercise. Life Sci 1981; 28: 1925
Hurwitz GA, Webb JG, Walle T, et al. Exercise-induced increments in plasma levels of propranolol and noradrenaline. Br J Clin Pharmacol 1983; 16: 599–608
Powis G, Snow DH. The effects of exercise and adrenaline infusion upon the blood levels of propranolol and antipyrine in the horse. J Pharm Exp Ther 1978; 205: 725–31
Dossing M. Effect of acute and chronic exercise on hepatic drug metabolism. Clin Pharmacokinet 1985; 10: 426–31
Joreteg T, Jorestrand T. Physical exercise and binding of digoxin to skeletal muscle: effect of muscle activation frequency. Eur J Clin Pharmacol 1984; 27: 567–70
Villa JG, Bayon JE, Gonzalez-Gallego J. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning. J Sports Med Phys Fitness 1999; 39: 197–201
Sweeney GD. Drags: some basic concepts. Med Sci Sports Exerc 1981; 13: 247–51
Suzuki M, Sudah M, Matsubaru S, et al. Changes in renal blood flow measured by radionuclide angiography following exhausting exercise in humans. Eur J Appl Physiol 1996; 74: 1–7
Stoschitzky K, Linder W, Klein W. Stereoselective release of Satenolol from adrenergic nerve endings at exercise. Lancet 1992; 340: 696–7
Ylitalo P, Hinkka M. Effects of exercise on plasma levels and urinary excretion of sulfadimidine and procainamide. Int J Clin Pharmacol Ther Toxicol 1985; 23: 548–53
McEvoy GK, editor. American Hospital Formulary Service Drug Information 2001. Bethesda (MD): American Society of Health-System Pharmacists, 2001
Mason WD, Kopchak G, Winer N, et al. Effect of exercise on the renal clearance of atenolol. J Pharm Sci 1980; 69: 344–5
Bruce RA. Exercise testing of patients with coronary artery disease [abstract]. Ann Clin Res 1971; 3: 323
Van Baak MA, Mooij JM, Schiffers PM. Exercise and the pharmacokinetics of propranolol, verapamil and atenolol. Eur J Clin Pharmacol 1992; 43: 547–50
GlaxoSmithKline. Coreg® (carvedilol) package insert. Research Triangle Park (NC): GlaxoSmithKline, 2001
Stoschitzky K, Koshucharova G, Zweiker R, et al. Unpredicted lack of effect of exercise on plasma concentrations of Carvedilol. J Cardiovasc Pharmacol 2002; 39: 58–60
Arends BG, Bohm ROB, van Kemenade JE, et al. Influence of physical exercise on the pharmacokinetics of propranolol. Eur J Clin Pharmacol 1986, 377
Panton LB, Guillen GJ, Williams L, et al. The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults. J Clin Pharmacol 1995; 35: 885–94
Mooy J, Arends B, Kemenade JV, et al. Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans. J Cardiovasc Pharmacol 1986; 8: 940–2
Ylitalo P, Hinkaa H, Neuvonen PJ. Effect of exercise on the serum level of urinary excretion of tetracycline, doxycycline and sulphamethizole. Eur J Clin Pharmacol 1977; 12: 367–73
Jogestrand T, Anderson K. Effect of physical exercise on the pharmacokinetics of digoxin during maintenance treatment. J Cardiovasc Pharmacol 1989; 14: 73–6
Pederson KE, Madsen J, Kjaer K, et al. Effects of physical activity and immobilization on plasma digoxin concentration and renal digoxin clearance. Clin Pharmacol Ther 1983; 34: 303–8
Grille W, Welter U, Johnson K, et al. Effects of physical activity on serum concentrations of digoxin and digitoxin. Eur J Clin Pharmacol 1996; 50: 237–9
Laursen SO, Pedersen KE, Klitgaard NA. Influence of physical activity on plasma digoxin in hospitalized patients. Dan Med Bull 1987; 34: 115–7
Jessup JV, Lowenthal DT, Pollock ML, et al. The effects of exercise training on the pharmacokinetics of digoxin. J Cardiopulm Rehabil 2000; 20: 89–95
Micromedex® healthcare series. Greenwood Village (CO): Thomson MICROMEDEX, edition 110 expires 2001 Dec
Shibata Y, Hashimoto H, Kurata C, et al. Influence of physical activity on warfarin therapy. Thromb Haemost 1998; 80: 203–4
Ryan AJ, Chang RT, Gisolfi CV. Gastrointestinal permeability following aspirin intake and prolonged exercise. Med Sci Sports Exerc 1996; 28(6): 698–705
Sawrymowicz M. The effect of exercise on the pharmacokinetics of acetaminophen and acetylsalicylic acid. Ann Acad Med Stetin 1997; 43: 57–66
Acknowledgements
There were no sources of funding or conflicts of interest from any author directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lenz, T.L., Lenz, N.J. & Faulkner, M.A. Potential Interactions between Exercise and Drug Therapy. Sports Med 34, 293–306 (2004). https://doi.org/10.2165/00007256-200434050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00007256-200434050-00002